Journal Of Clinical Oncology (jco) Podcast
No Advantage to Combining Cetuximab with 5FU, Leucovorin, and Oxaliplatin in Metastatic Colorectal Cancer
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:06:44
- More information
Informações:
Synopsis
This podcast reviews a negative phase III clinical trial of cetuximab combined with chemotherapy in first-line metastatic colorectal cancer and focuses on the interaction of targeted therapy combined with chemotherapy.
